108 related articles for article (PubMed ID: 31322990)
21. Association of Actual and Preferred Decision Roles With Patient-Reported Quality of Care: Shared Decision Making in Cancer Care.
Kehl KL; Landrum MB; Arora NK; Ganz PA; van Ryn M; Mack JW; Keating NL
JAMA Oncol; 2015 Apr; 1(1):50-8. PubMed ID: 26182303
[TBL] [Abstract][Full Text] [Related]
22. Information preferences regarding cure rates and prognosis of Austrian patients with advanced lung cancer.
Rumpold T; Lütgendorf-Caucig C; Jagsch R; Dieckmann K; Watzke H; Pötter R; Kirchheiner K
Strahlenther Onkol; 2015 Jul; 191(7):549-56. PubMed ID: 25690939
[TBL] [Abstract][Full Text] [Related]
23. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer.
Davis KL; Goyal RK; Able SL; Brown J; Li L; Kaye JA
Lung Cancer; 2015 Feb; 87(2):176-85. PubMed ID: 25532680
[TBL] [Abstract][Full Text] [Related]
24. Baseline quality of life is associated with survival among people with advanced lung cancer.
Trejo MJ; Bell ML; Dhillon HM; Vardy JL
J Psychosoc Oncol; 2020; 38(5):635-641. PubMed ID: 32410506
[TBL] [Abstract][Full Text] [Related]
25. Clinical decision-making and health-related quality of life during first-line and maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC): findings from a real-world setting.
Sztankay M; Giesinger JM; Zabernigg A; Krempler E; Pall G; Hilbe W; Burghuber O; Hochmair M; Rumpold G; Doering S; Holzner B
BMC Cancer; 2017 Aug; 17(1):565. PubMed ID: 28835219
[TBL] [Abstract][Full Text] [Related]
26. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
Busolo D; Woodgate R
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
[TBL] [Abstract][Full Text] [Related]
27. Impact of Health-Related Quality of Life and Prediagnosis Risk of Major Depressive Disorder on Treatment Choice for Stage I Lung Cancer.
van Dams R; Grogan T; Lee P; Punglia R; Raldow A
JCO Clin Cancer Inform; 2019 Sep; 3():1-8. PubMed ID: 31545654
[TBL] [Abstract][Full Text] [Related]
28. Does timeliness of care in Non-Small Cell Lung Cancer impact on survival?
Vinod SK; Chandra A; Berthelsen A; Descallar J
Lung Cancer; 2017 Oct; 112():16-24. PubMed ID: 29191589
[TBL] [Abstract][Full Text] [Related]
29. Distance from accessible specialist care and other determinants of advanced or unknown stage at diagnosis of people with non-small cell lung cancer: A data linkage study.
Tracey E; McCaughan B; Badgery-Parker T; Young J; Armstrong B
Lung Cancer; 2015 Oct; 90(1):15-21. PubMed ID: 26275475
[TBL] [Abstract][Full Text] [Related]
30. Association Between Treatment Facility Volume, Therapy Types, and Overall Survival in Patients With Stage IIIA Non-Small Cell Lung Cancer.
Kommalapati A; Tella SH; Appiah AK; Smith L; Ganti AK
J Natl Compr Canc Netw; 2019 Mar; 17(3):229-236. PubMed ID: 30865920
[TBL] [Abstract][Full Text] [Related]
31. Dying with cancer: patients' function, symptoms, and care preferences as death approaches.
McCarthy EP; Phillips RS; Zhong Z; Drews RE; Lynn J
J Am Geriatr Soc; 2000 May; 48(S1):S110-21. PubMed ID: 10809464
[TBL] [Abstract][Full Text] [Related]
32. Who gets chemotherapy for metastatic lung cancer?
Earle CC; Venditti LN; Neumann PJ; Gelber RD; Weinstein MC; Potosky AL; Weeks JC
Chest; 2000 May; 117(5):1239-46. PubMed ID: 10807806
[TBL] [Abstract][Full Text] [Related]
33. Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study.
Hui R; Özgüroğlu M; Villegas A; Daniel D; Vicente D; Murakami S; Yokoi T; Chiappori A; Lee KH; de Wit M; Cho BC; Gray JE; Rydén A; Viviers L; Poole L; Zhang Y; Dennis PA; Antonia SJ
Lancet Oncol; 2019 Dec; 20(12):1670-1680. PubMed ID: 31601496
[TBL] [Abstract][Full Text] [Related]
34. Qualitative Development and Content Validity of the Non-small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome Instrument.
McCarrier KP; Atkinson TM; DeBusk KP; Liepa AM; Scanlon M; Coons SJ;
Clin Ther; 2016 Apr; 38(4):794-810. PubMed ID: 27041408
[TBL] [Abstract][Full Text] [Related]
35. Prospective analysis of patient reported symptoms and quality of life in patients with incurable lung cancer treated in a rapid access clinic.
Lefresne S; Olson R; Cashman R; Kostuik P; Jiang WN; Levy K; Mckenzie MR; Hulstyn A; Liu M; Wu J; Berthelet E
Lung Cancer; 2017 Oct; 112():35-40. PubMed ID: 29191598
[TBL] [Abstract][Full Text] [Related]
36. Factors Associated With Treatment of Clinical Stage I Non-Small-cell Lung Cancer: A Population-based Analysis.
Berry MF; Canchola AJ; Gensheimer MF; Gomez SL; Cheng I
Clin Lung Cancer; 2018 Sep; 19(5):e745-e758. PubMed ID: 30149883
[TBL] [Abstract][Full Text] [Related]
37. The impact of comorbidity upon determinants of outcome in patients with lung cancer.
Grose D; Morrison DS; Devereux G; Jones R; Sharma D; Selby C; Docherty K; McIntosh D; Nicolson M; McMillan DC; Milroy R;
Lung Cancer; 2015 Feb; 87(2):186-92. PubMed ID: 25498829
[TBL] [Abstract][Full Text] [Related]
38. Treatment and survival disparities in lung cancer: the effect of social environment and place of residence.
Johnson AM; Hines RB; Johnson JA; Bayakly AR
Lung Cancer; 2014 Mar; 83(3):401-7. PubMed ID: 24491311
[TBL] [Abstract][Full Text] [Related]
39. Patients' preferred and perceived roles in making decisions about adjuvant chemotherapy for non-small-cell lung cancer.
Moth E; McLachlan SA; Veillard AS; Muljadi N; Hudson M; Stockler MR; Blinman P
Lung Cancer; 2016 May; 95():8-14. PubMed ID: 27040845
[TBL] [Abstract][Full Text] [Related]
40. Preferences of patients with advanced lung cancer regarding the involvement of family and others in medical decision-making.
Pardon K; Deschepper R; Stichele RV; Bernheim JL; Mortier F; Bossuyt N; Schallier D; Germonpré P; Galdermans D; Van Kerckhoven W; Deliens L;
J Palliat Med; 2010 Oct; 13(10):1199-203. PubMed ID: 20849278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
